](https://i.ytimg.com/vi/bHabcAgvFSg/maxresdefault.jpg)
A Q&A On Comprehensive Genomic Profiling in rare cancers and cancer of unknown primary.
4 意见
• 07/10/23
0
0
嵌入
A Q&A with TargetCancer Foundation on Comprehensive Genomic Profiling and its relevance in rare cancers and cancer of unknown primary, as well as its incorporation in the TRACK Study.
Featuring:
Jim Palma, Executive Director, TargetCancer Foundation
Dr. Prasanth Reddy, VP of Medical Affairs, Foundation Medicine
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论